SPH3348
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SPH3348, covering 2024-10-22 to 2024-10-22. Get the full timeline:
Most recent: Clinical Trial Update: SPH3348 Tablets in a Single-center, Randomized, Open-label, Single-dose, Two-period, Two-sequence Crossover Design Food Effect Study in Healthy Chinese Subjects [Phase 1]